HIPEC with oxaliplatin in the treatment of peritoneal carcinomatosis of colorectal origin

Peritoneal Carcinomatosis: A Multidisciplinary Approach

Volumn , Issue , 2007, Pages 303-318

  Elias, Dominique ^a   Pocard, Marc ^a   Goere, Diane ^a  

^a INSTITUT GUSTAVE ROUSSY   (France)

Author keywords

[No Author keywords available]

Indexed keywords

ANTINEOPLASTIC AGENT; CAMPTOTHECIN; DRUG DERIVATIVE; IRINOTECAN; OXALIPLATIN; PLATINUM COMPLEX;

ARTICLE; CARCINOMA; CLINICAL TRIAL; COLORECTAL TUMOR; COMPARATIVE STUDY; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DRUG THERAPY; FEMALE; HUMAN; HYPERTHERMIC THERAPY; INFUSION; MALE; METASTASIS; METHODOLOGY; MORTALITY; PATHOLOGY; PERITONEUM TUMOR; PHASE 1 CLINICAL TRIAL; PHASE 2 CLINICAL TRIAL; REGIONAL PERFUSION; SURVIVAL RATE; TREATMENT OUTCOME;

ANTINEOPLASTIC AGENTS; CAMPTOTHECIN; CARCINOMA; CHEMOTHERAPY, CANCER, REGIONAL PERFUSION; COLORECTAL NEOPLASMS; DRUG THERAPY; FEMALE; HUMANS; HYPERTHERMIA, INDUCED; INFUSIONS, PARENTERAL; MALE; ORGANOPLATINUM COMPOUNDS; PERITONEAL NEOPLASMS; SURVIVAL RATE; TREATMENT OUTCOME;

EID: 34548381800     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1007/978-0-387-48993-3_19     Document Type: Chapter

References (33)

1. Elias D, Detroz B, Debaene B, Damia E, Leclercq B, Rougier P, et al (1994) Treatment of peritoneal carcinomatosis by intraperitoneal chemohyperthermia: reliable and unreliable concepts. Hepatogastroenterol 41: 207-213
2. Sugarbaker PH. Intraperitoneal chemotherapy and (1998) cytoreductive surgery for the prevention and treatment of peritoneal carcinomatosis and sarcomatosis. Semin Surg Oncol 14: 254-261
3. Yonemura Y, Fujimura T, Nishimura G, Falla R, Sawa T, Katayama K, et al (1996) Effects of intraoperative chemohyperthermia in patients with gastric cancer with peritoneal dissemination. Surgery 119: 437-444
4. Elias D, Antoun A, Goharin A, El Otmany A., Puizillout JM, Lasser P (2000) Research on the best chemohyperthermia technique for treatment of peritoneal carcinomatosis after complete resection. Int J Surg Invest 1: 431-439
5. Fujimoto S, Shresta RD, Kokubun M, Kobayashi K, Kiushu S, Konna C et al (1990) Positive results of combined therapy of surgery and intraperitoneal hyperthermic perfusion for far advanced gastric cancer. Ann Surg 212: 592-596
6. Hamazoe R, Maeta M, Keibara N (1994) Intraperitoneal thermochemotherapy for prevention of peritoneal recurrence of gastric cancer. Cancer 73: 2048-2052
7. Van der Vaart PJ, van der Vange N, Zoetmulder FA, van Goethtel AR, van Tellingen O, ten Bokkel WW, et al (1998) Intraperitoneal cisplatin with regional hyperthermia in advanced ovarian cancer: pharmacokinetics and cisplatin-DNA adducts formation in patients and ovarian cancer cell lines. Eur J Cancer 34 : 148-154
8. Becouarn Y, Ychou M, Ducreux M, Borel C, Bertheault-Cvitkovic F, Seitz JF, et al (1998) Phase II trial of oxaliplatin as first line chemotherapy in metastatic colorectal cancer. J Clin Oncol 16 : 2739-2744
9. Giachetti S, Perpoint B, Zidani R, Le Bail R, Faggiuolo R, Focan C, et al (2000) Phase III multicenter randomized trial of oxaliplatin added to chronomoduled fluorouracil-leucovorin as first line treatment of metastatic colorectal cancer. J Clin Oncol 18 : 136-147
10. De Gramont A, Figer A, Seymour M, Homerin M, Hmissi A, Cassidy J, et al (2000) Leucovorin and fluorouracil with or without oxaliplatin as first line treatment in advanced colorectal cancer. J Clin Oncol 18: 2938-2947
11. Sugarbaker PH, Cuniffe W, Belliveau JF, de Bruin E, Graves T (1988) Rationale for perioperative intraperitoneal chemotherapy as a surgical adjuvant for gastrointestinal malignancy. Reg Cancer Treat 1: 66-79
12. Sugarbaker PH, Jablonski KH (1995) Prognostic features of 51 colorectal and 130 appendiceal cancer patients with peritoneal carcinomatosis treated by cytoreductive surgery and intraperitoneal chemotherapy. Ann Surg 221: 124-132
13. Elias D, Gachot B, Bonvalot S, Blot F, Sabourin JC, Ducreux M, et al (1997) Carcinoses péritonéales traitées par exérèse complète et chimiothérapie intrapéritonéale postopératoire immédiate (CIPPI). Etude de phase II portant sur 54 malades. Gastroenterol Clin Biol 21: 181-187
14. Didkhoff T, van der Heider J, Dubbelman R, ten Bokkel Huinink W (1985) Tissue concentration of platinum after intraperitoneal cisplatin administration in patients. Proc AACR 26: 162
15. Zoetmulder FA (1996) Cancer cell seeding during abdominal surgery: experimental studies. In: Peritoneal carcinomatosis: principles of management, P.H. Sugarbaker (ed.), Kluwer Acad Pubisher, Boston; p155-162
16. Jacquet P, Elias D, Sugarbaker P (1996) L'implantation tumorale dans les sites de cicatrisation après chirurgie des cancers digestifs. J Chir (Paris) 133: 175-182
17. Rietbroeck RC, van de Vaart PJ, Haveman J, Blommaert FA, Geerdink A, Bakker PJ, et al (1997) Hyperthermia enhances the cytotoxicity and platinum-DNA adducts formation of lobaplatin and oxaliplatin in cultured SW 1573 cells. J Cancer Res Clin Oncol 123: 6-12
18. Hahn GM (1979) Potential for therapy of drugs and hyperthermia. Cancer Res 39: 2264-2268
19. Sugarbaker PH (1995) Peritonectomy procedures. Ann Surg 221: 29-42
20. Song CW, Shakil A, Osborn JL, Iwata K (1996) Tumour oxygenation is increased by hyperthermia at mild temperatures. In J Hyperthermia 12: 367-373 Ann Oncology 13: 267-272
21. Elias D, Bonnay M, Puizillou JM, Antoun S, Demirdjian S, El Otmany A, et al (2002) Heated intraoperative intraperitoneal oxaliplatin after complete resection of peritoneal carcinomatosis: pharmacokinetic and tissue distribution. Ann Oncology 13: 267-272
22. Elias D, El Otmany A, Bonnay M, Paci A, Ducreux M, Antoun S, et al (2002) Human pharmacokinetic study of heated intraperitoneal oxaliplatin in increasingly hypotonic solutions, after complete resection of peritoneal carcinomatosis. Oncology 63: 346-352
23. Groose E, Walker L, Masters JR (1986) The influence of osmolarity on drug cytotoxicity in vitro. Br J Cancer 54: 181-182
24. Smith E, Brock AP (1989) The effect of reduced osmolarity on platinum drug cytotoxicity. Br J Cancer 59: 873-875
25. Tsujitani S, Oka A, Kondo A, Katano K, Oka S, Saito H, et al (1999) Administration in a hypotonic solution is preferable to dose escalation in intraperitoneal cisplatin chemotherapy for peritoneal carcinomatosis in rats. Oncology 57: 77-82
26. Elias D, Raynard B, Farkhondeh F, Goéré D, Rouquie D, Ciuchende R, et al (2006) Peritoneal carcinomatosis of colorectal origin: long-term results of intraperitoneal chemohyperthermia with oxaliplatin following complete cytoreductive surgery. Gastroenterol Clin Biol (in press).
27. Verwaal VJ, van Ruth S, Witkamp A, Boot H, van Slooten G, Zoetmulder F (2005) Long-term survival of peritoneal carcinomatosis of colorectal origin. Ann Surg Oncol 12: 65-71
28. Piso P, Bektas H, Werner U, Schiltt HJ, Kubicka S, Bornscheuer A, et al (2001) Improved prognosis following perinectomy procedures and hyperthermic intraperitoneal chemotherapy for peritoneal carcinomatosis from appendiceal carcinoma. Eur J Surg Oncol 27: 286-290
29. Jayne DG, Fook S, Loi C, Seow-Choen F (2002) Peritoneal carcinomatosis from colorectal cancer. Br J Surg 89; 1545-1550
30. Verwaal VC, van Ruth S, de Bree E, van Sloten GW, van Tinteren H, Boot H, et al (2003) Randomized trial of cytoreduction and hyperthermic intraperitoneal chemotherapy versus systemic chemotherapy and palliative surgery in patients with peritoneal carcinomatosis from colorectal cancer. J Clin Oncol 21: 3737-3743
31. Feldman L, Barkun J, Barkun A, Sampalis J, Rosenberg L (1997) Measuring postoperative complications in general surgery patients using an out-come-based strategy: comparison with complications presented at morbidity and mortality rounds. Surgery 122: 711-720
32. Elias D, Matsuhisa T, Sideris L, Liberale G, Drouard-Troalen L, Raynard B, Pocard M, Puizillou JM, Billard V, Bourget P, Ducreux M (2004) Heated intra-operative intraperitoneal oxaliplatin plus irinotecan after complete resection of peritoneal carcinomatosis: pharmacokinetics, tissue distribution and tolerance. Ann Oncol 15: 1558-1565
33. Elias D, Raynard B, Boige V, Laplanche A, Estphan G, Malka D, Pocard M (2005) Impact of the extent and duration of cytoreductive surgery on postoperative haematological toxicity after intraperitoneal chemohyperthermia for peritoneal carcinomatosis. J Surg Oncol 90: 220-225